Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders.
$20.06-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+1.1%
The outlook
Seaport Therapeutics, Inc. currently reads as bullish based on strong buy — 1.5 avg of 5 analysts, above its 50- & 200-day averages, 63% of the way from its 52-week low to high, avg target +90% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range64% of the way from its 52-week low to high
Price targetAvg target +89% vs current price
Analyst price target
~12-month · 5 analysts$38.00average target+89.4% vs now
Now $20.06
Low $30.00High $50.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.07B
52-wk high
$23.00
52-wk low
$14.85
50-day avg
$19.09
200-day avg
$18.58
Trailing P/E
—